Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: ALKBH5-Mediated m6A Modification Drives Apoptosis in Renal Tubular Epithelial Cells by Negatively Regulating MUC1. | Mol Biotechnol | 2025 | 40088410 | PubTator, text mining | PubMed |
| AC074117.1/miR-193a-3p axis regulates the malignant progression of uterine corpus endometrial carcinoma via the m6A-related gene ALKBH5. | Am J Med Sci | 2025 | 40064293 | PubTator, text mining | PubMed |
| Epigenetic targets and their inhibitors in the treatment of idiopathic pulmonary fibrosis. | Eur J Med Chem | 2025 | 40048798 | PubTator, text mining | PubMed |
| Circuit logic: interdependent RNA modifications shape mRNA and noncoding RNA structure and function. | RNA | 2025 | 40044218 | PubTator, text mining | PubMed |
| Development of 3-arylaminothiophenic-2-carboxylic acid derivatives as new FTO inhibitors showing potent antileukemia activities. | Eur J Med Chem | 2025 | 40022879 | PubTator, text mining | PubMed |
| The m6A demethylase FTO promotes C/EBPβ-LIP translation to perform oncogenic functions in breast cancer cells. | FEBS J | 2025 | 40022434 | PubTator, text mining | PubMed |
| Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling. | Science | 2025 | 40014709 | PubTator, text mining | PubMed |
| Novel Insight of N6-Methyladenosine in Cardiovascular System. | Medicina (Kaunas) | 2025 | 40005339 | PubTator, text mining | PubMed |
| M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms. | Biomolecules | 2025 | 40001461 | PubTator, text mining | PubMed |
| Editorial: The emerging role of protein methylation/demethylation modification in disease and homeostasis. | Front Mol Biosci | 2025 | 39995569 | PubTator, text mining | PubMed |
| Prognostic value of IFI27 in HNSCC and functional analysis under ALKBH5 regulation. | Sci Rep | 2025 | 39994291 | PubTator, text mining | PubMed |
| DNA hypermethylation-induced suppression of ALKBH5 is required for folic acid to alleviate hepatic lipid deposition by enhancing autophagy in an ATG12-dependent manner. | J Nutr Biochem | 2025 | 39993647 | PubTator, text mining | PubMed |
| USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. | Theranostics | 2025 | 39990235 | PubTator, text mining | PubMed |
| m6A eraser ALKBH5/treRNA1/DDX46 axis regulates BCR expression. | Neoplasia | 2025 | 39987653 | PubTator, text mining | PubMed |
| Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation. | Int J Oncol | 2025 | 39981934 | PubTator, text mining | PubMed |
| Discovery of Covalent and Cell-Active ALKBH5 Inhibitors with Potent Antileukemia Effects In Vivo. | Angew Chem Int Ed Engl | 2025 | 39976119 | PubTator, text mining | PubMed |
| TDP-43/ALKBH5-mediated m6A modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1/S cell cycle transition. | MedComm (2020) | 2025 | 39974663 | PubTator, text mining | PubMed |
| The Mechanisms, Research Status, and Future Prospects of m6A Modification in Breast Cancer. | J Gene Med | 2025 | 39972939 | PubTator, text mining | PubMed |
| KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer. | J Clin Invest | 2025 | 39960727 | PubTator, text mining | PubMed |
| Exosomal ALKBH5 Alleviates Vascular Calcification by Suppressing Cell Apoptosis via m6A-Modified GSDME. | Drug Dev Res | 2025 | 39950329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=18